vs

Side-by-side financial comparison of COMMUNITY HEALTH SYSTEMS INC (CYH) and Kyndryl Holdings, Inc. (KD). Click either name above to swap in a different company.

Kyndryl Holdings, Inc. is the larger business by last-quarter revenue ($3.9B vs $3.1B, roughly 1.2× COMMUNITY HEALTH SYSTEMS INC). COMMUNITY HEALTH SYSTEMS INC runs the higher net margin — 3.5% vs 1.5%, a 2.1% gap on every dollar of revenue. On growth, Kyndryl Holdings, Inc. posted the faster year-over-year revenue change (3.1% vs -4.8%). Kyndryl Holdings, Inc. produced more free cash flow last quarter ($208.0M vs $172.0M). Over the past eight quarters, Kyndryl Holdings, Inc.'s revenue compounded faster (0.1% CAGR vs -0.5%).

Community Health Systems (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

Kyndryl Holdings, Inc. is an American multinational information technology infrastructure services provider, headquartered in New York City and created from the spin-off of IBM's infrastructure services business in 2021. The company designs, builds, manages and develops large-scale information systems. The company also has business advisory services. It is currently the world's largest IT infrastructure services provider, and the fifth-largest consulting provider.

CYH vs KD — Head-to-Head

Bigger by revenue
KD
KD
1.2× larger
KD
$3.9B
$3.1B
CYH
Growing faster (revenue YoY)
KD
KD
+7.9% gap
KD
3.1%
-4.8%
CYH
Higher net margin
CYH
CYH
2.1% more per $
CYH
3.5%
1.5%
KD
More free cash flow
KD
KD
$36.0M more FCF
KD
$208.0M
$172.0M
CYH
Faster 2-yr revenue CAGR
KD
KD
Annualised
KD
0.1%
-0.5%
CYH

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CYH
CYH
KD
KD
Revenue
$3.1B
$3.9B
Net Profit
$110.0M
$57.0M
Gross Margin
85.6%
21.8%
Operating Margin
14.5%
2.4%
Net Margin
3.5%
1.5%
Revenue YoY
-4.8%
3.1%
Net Profit YoY
254.9%
-73.5%
EPS (diluted)
$0.82
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYH
CYH
KD
KD
Q4 25
$3.1B
$3.9B
Q3 25
$3.1B
$3.7B
Q2 25
$3.1B
$3.7B
Q1 25
$3.2B
$3.8B
Q4 24
$3.3B
$3.7B
Q3 24
$3.1B
$3.8B
Q2 24
$3.1B
$3.7B
Q1 24
$3.1B
$3.9B
Net Profit
CYH
CYH
KD
KD
Q4 25
$110.0M
$57.0M
Q3 25
$130.0M
$68.0M
Q2 25
$282.0M
$56.0M
Q1 25
$-13.0M
$69.0M
Q4 24
$-71.0M
$215.0M
Q3 24
$-391.0M
$-43.0M
Q2 24
$-13.0M
$11.0M
Q1 24
$-41.0M
$-45.0M
Gross Margin
CYH
CYH
KD
KD
Q4 25
85.6%
21.8%
Q3 25
85.1%
21.5%
Q2 25
85.0%
21.3%
Q1 25
84.5%
21.7%
Q4 24
84.5%
20.4%
Q3 24
84.8%
19.9%
Q2 24
84.6%
21.5%
Q1 24
84.5%
18.6%
Operating Margin
CYH
CYH
KD
KD
Q4 25
14.5%
2.4%
Q3 25
7.9%
2.6%
Q2 25
16.3%
2.5%
Q1 25
9.0%
3.1%
Q4 24
8.5%
6.9%
Q3 24
-6.6%
-0.1%
Q2 24
7.6%
1.7%
Q1 24
7.4%
-0.1%
Net Margin
CYH
CYH
KD
KD
Q4 25
3.5%
1.5%
Q3 25
4.2%
1.8%
Q2 25
9.0%
1.5%
Q1 25
-0.4%
1.8%
Q4 24
-2.2%
5.7%
Q3 24
-12.7%
-1.1%
Q2 24
-0.4%
0.3%
Q1 24
-1.3%
-1.2%
EPS (diluted)
CYH
CYH
KD
KD
Q4 25
$0.82
$0.25
Q3 25
$0.96
$0.29
Q2 25
$2.09
$0.23
Q1 25
$-0.10
$0.30
Q4 24
$-0.53
$0.89
Q3 24
$-2.95
$-0.19
Q2 24
$-0.10
$0.05
Q1 24
$-0.32
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYH
CYH
KD
KD
Cash + ST InvestmentsLiquidity on hand
$260.0M
$1.3B
Total DebtLower is stronger
$10.4B
$2.3B
Stockholders' EquityBook value
$-1.4B
$1.2B
Total Assets
$13.2B
$11.3B
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYH
CYH
KD
KD
Q4 25
$260.0M
$1.3B
Q3 25
$123.0M
$1.3B
Q2 25
$456.0M
$1.5B
Q1 25
$431.0M
$1.8B
Q4 24
$37.0M
$1.5B
Q3 24
$33.0M
$1.3B
Q2 24
$39.0M
$1.3B
Q1 24
$48.0M
$1.6B
Total Debt
CYH
CYH
KD
KD
Q4 25
$10.4B
$2.3B
Q3 25
$3.0B
Q2 25
$3.0B
Q1 25
$3.0B
Q4 24
$11.5B
$3.1B
Q3 24
$3.1B
Q2 24
$3.1B
Q1 24
$3.1B
Stockholders' Equity
CYH
CYH
KD
KD
Q4 25
$-1.4B
$1.2B
Q3 25
$-1.5B
$1.2B
Q2 25
$-1.6B
$1.2B
Q1 25
$-1.9B
$1.2B
Q4 24
$-1.9B
$1.1B
Q3 24
$-1.8B
$1.1B
Q2 24
$-1.4B
$996.0M
Q1 24
$-1.4B
$1.0B
Total Assets
CYH
CYH
KD
KD
Q4 25
$13.2B
$11.3B
Q3 25
$13.2B
$11.2B
Q2 25
$13.6B
$11.5B
Q1 25
$13.9B
$10.5B
Q4 24
$14.1B
$9.9B
Q3 24
$13.9B
$10.4B
Q2 24
$14.4B
$10.2B
Q1 24
$14.4B
$10.6B
Debt / Equity
CYH
CYH
KD
KD
Q4 25
1.92×
Q3 25
2.45×
Q2 25
2.44×
Q1 25
2.50×
Q4 24
2.81×
Q3 24
2.92×
Q2 24
3.12×
Q1 24
3.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYH
CYH
KD
KD
Operating Cash FlowLast quarter
$266.0M
$428.0M
Free Cash FlowOCF − Capex
$172.0M
$208.0M
FCF MarginFCF / Revenue
5.5%
5.4%
Capex IntensityCapex / Revenue
3.0%
5.7%
Cash ConversionOCF / Net Profit
2.42×
7.51×
TTM Free Cash FlowTrailing 4 quarters
$208.0M
$299.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYH
CYH
KD
KD
Q4 25
$266.0M
$428.0M
Q3 25
$69.0M
$146.0M
Q2 25
$88.0M
$-124.0M
Q1 25
$120.0M
$581.0M
Q4 24
$216.0M
$260.0M
Q3 24
$67.0M
$149.0M
Q2 24
$101.0M
$-48.0M
Q1 24
$96.0M
$145.0M
Free Cash Flow
CYH
CYH
KD
KD
Q4 25
$172.0M
$208.0M
Q3 25
$4.0M
$17.0M
Q2 25
$-3.0M
$-267.0M
Q1 25
$35.0M
$341.0M
Q4 24
$107.0M
$151.0M
Q3 24
$-3.0M
$15.0M
Q2 24
$13.0M
$-170.0M
Q1 24
$3.0M
$-57.0M
FCF Margin
CYH
CYH
KD
KD
Q4 25
5.5%
5.4%
Q3 25
0.1%
0.5%
Q2 25
-0.1%
-7.1%
Q1 25
1.1%
9.0%
Q4 24
3.3%
4.0%
Q3 24
-0.1%
0.4%
Q2 24
0.4%
-4.5%
Q1 24
0.1%
-1.5%
Capex Intensity
CYH
CYH
KD
KD
Q4 25
3.0%
5.7%
Q3 25
2.1%
3.5%
Q2 25
2.9%
3.8%
Q1 25
2.7%
6.3%
Q4 24
3.3%
2.9%
Q3 24
2.3%
3.6%
Q2 24
2.8%
3.3%
Q1 24
3.0%
5.2%
Cash Conversion
CYH
CYH
KD
KD
Q4 25
2.42×
7.51×
Q3 25
0.53×
2.15×
Q2 25
0.31×
-2.21×
Q1 25
8.42×
Q4 24
1.21×
Q3 24
Q2 24
-4.36×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CYH
CYH

Managed Care And Other Third Party Payors$1.5B49%
Medicare Managed Care$570.0M18%
Medicare$512.0M16%
Medicaid$464.0M15%
Self Pay Revenue$34.0M1%

KD
KD

Principal Markets Segment$1.4B37%
United States Segment$958.0M25%
Strategic Markets Segment$905.0M23%
Other$568.0M15%

Related Comparisons